Is the next quarterly report. All the other stuff is just fluff. Manipulation from insiders and outsiders. Last quarterly report showed Avenova sales shoot real high. This upcoming report will confirm it's acceptance or if that was just discounted sales manipulation. If numbers are bad then expect delisting next year. If numbers are as good as last report then don't sell until it hits $5. I am long on this one.
I am only upset that I could have sold in the $0.90s and repurchased a higher quantity in the $0.60's but I agree with you. It was expected. I wouldn't want to be the one who sold hoping to get back in at a lower price and before rebuying gets hit with some major positive news with price opening higher than where I sold it at.
I agree. And they also filed a "Confidential treatment order" last week on 04-15 with the SEC. They stated they left something off the annual report. I understand it could be anything but it seems there is something brewing. Acquisition. Buyout. You never know. If it was supposed to be that bad then insiders wouldn't have been buying recently.